Turnstone Biologics Corp.
TSBX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $29 | $18 | $35 | $123 |
| Short-Term Investments | $0 | $77 | $47 | $38 |
| Receivables | $0 | $0 | $9 | $7 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $5 | $8 | $7 | $9 |
| Total Curr. Assets | $34 | $103 | $98 | $177 |
| Property Plant & Equip (Net) | $5 | $9 | $14 | $9 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $0 | $0 | $0 | $0 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $3 | $1 |
| Total NC Assets | $6 | $10 | $17 | $10 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $40 | $113 | $115 | $187 |
| Liabilities | – | – | – | – |
| Payables | $1 | $0 | $3 | $0 |
| Short-Term Debt | $1 | $4 | $4 | $1 |
| Tax Payable | $1 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $15 | $33 |
| Other Curr. Liab. | $5 | $8 | $12 | $20 |
| Total Curr. Liab. | $8 | $12 | $35 | $55 |
| LT Debt | $0 | $1 | $3 | $2 |
| Deferred Rev, NC | $0 | $0 | $4 | $39 |
| Deferred Tax Liab, NC | $0 | $0 | $172 | $172 |
| Other NC Liab. | $0 | $1 | $2 | $1 |
| Total NC Liab. | $0 | $2 | $182 | $214 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $1 | $3 | $5 | $3 |
| Total Liabilities | $9 | $14 | $216 | $269 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $172 | $172 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$248 | -$177 | -$122 | -$91 |
| AOCI | -$0 | -$0 | -$0 | -$0 |
| Other Equity | $279 | $276 | -$151 | -$163 |
| Total Equity | $31 | $99 | -$101 | -$82 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $40 | $113 | $115 | $187 |
| Net Debt | -$28 | -$13 | -$28 | -$120 |